US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Vertex Pharmaceuticals Inc (VRTX)
Vertex Pharmaceuticals Inc (VRTX) ニュース

VRTX

Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VRTX

<< 前へ 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/08/05	21 : 45	TipRanks	Analysts Offer Insights on Healthcare Companies: AVEO Pharma (AVEO), Vertex Pharmaceuticals (VRTX) and Bausch + Lomb Corporation (BLCO)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/08/05	19 : 24	TipRanks	H.C. Wainwright Keeps a Buy Rating on Vertex Pharmaceuticals (VRTX)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/08/05	05 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/08/05	05 : 01	Business Wire	Vertex Reports Second Quarter 2022 Financial Results	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/08/03	05 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/27	15 : 15	TipRanks	SVB Securities Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/22	21 : 00	Business Wire	Vertex Advances VX-548 in Acute and Neuropathic Pain	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/22	05 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/21	06 : 52	Dow Jones News	Verve Therapeutics Shares Fall 14%, Company Commences Public Offering	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/21	05 : 01	GlobeNewswire Inc.	Vertex and Verve Therapeutics Establish Collaboration to Discover and Develop an In Vivo Gene Editing Program for Liver Disease	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/20	05 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/19	05 : 05	Business Wire	Vertex to Announce Second Quarter 2022 Financial Results on August 4	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/14	15 : 15	TipRanks	Wall Street Analysts Are Neutral on Top Healthcare Picks	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/11	21 : 14	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/11	21 : 00	Business Wire	Vertex to Acquire ViaCyte, With the Goal of Accelerating its Potentially Curative VX-880 Programs in Type 1 Diabetes	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/09	11 : 06	TipRanks	Vertex Pharmaceuticals (VRTX) Gets a Hold Rating from RBC Capital	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/08	11 : 45	TipRanks	Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), AbbVie (ABBV) and Sarepta Therapeutics (SRPT)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/08	03 : 36	PR Newswire (Canada)	Vertex procède à l'annonce de la lettre d'intention avec l'Alliance pancanadienne pharmaceutique pour le remboursement public de TRIKAFTA(MD) (éléxacaftor/tézacaftor/ivacaftor et ivacaftor) chez les enfants âgés de 6 ans et plus atteints de fibrose	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/08	03 : 26	PR Newswire (Canada)	Vertex Announces Letter of Intent With the pan-Canadian Pharmaceutical Alliance for Public Reimbursement of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 and Older	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/06	06 : 09	Business Wire	Vertex annonce que la FDA a levé la suspension clinique de l'essai clinique de phase 1/2 du VX-880 pour le traitement du diabète de type 1	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/06	06 : 09	Business Wire	Vertex: FDA hebt Stopp der klinischen Phase 1/2-Studie zu VX-880 für die Behandlung von Typ 1 Diabetes auf	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/05	21 : 45	Dow Jones News	Vertex: FDA Lifts Clinical Hold on VX-880 Study in Type 1 Diabetes	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/05	21 : 00	Business Wire	Vertex Announces FDA Has Lifted the Clinical Hold on VX-880 Phase 1/2 Clinical Trial for the Treatment of Type 1 Diabetes	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/07/04	11 : 48	TipRanks	Vertex Pharmaceuticals (VRTX) Receives a Hold from SVB Securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/06/29	05 : 06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/06/14	20 : 35	TipRanks	Maxim Group Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/06/14	10 : 45	TipRanks	Vertex Pharmaceuticals (VRTX) Gets a Hold Rating from RBC Capital	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/06/11	16 : 00	Business Wire	Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the 2022 European Hematology Association (EHA) Congress	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/06/11	00 : 00	Business Wire	Vertex to Present Data Demonstrating Significant Benefits of Long-Term and Early Treatment With CFTR Modulators at the European Cystic Fibrosis Conference	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/06/09	05 : 05	Business Wire	Vertex to Participate in the Goldman Sachs 43rd Annual Healthcare Conference on June 15	NASDAQ:VRTX	Vertex Pharmaceuticals Inc

Showing the most relevant articles for your search:NASDAQ:VRTX

<< 前へ 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 次へ >>

JP Morgan Chase

Gold vs US Dollar

Financial Select Sector

US Dollar vs Euro

US Dollar vs Yen

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約